Monitoring response to treatment in the development of anticancer drugs using PET.
Price
P
P
Cancer Research Campaign, PET Oncology Programme, Hammersmith Hospital, London, UK.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002250:Carbon Radioisotopes / Q000493:pharmacokinetics; D016903:Drug Monitoring / Q000379:methods*; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013936:Thymidine / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D013936:Thymidine